Valproic acid Completed Phase 2 Trials for Mesothelioma, Malignant Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00634205Phase II Study of Valproate and Doxorubicin in Malignant Mesothelioma